Home
>
National Drug Code (NDC)
>
Metoclopramide
Metoclopramide - 0228-2269-10 - (Metoclopramide)
Drug Information of Metoclopramide
| Product NDC: | 0228-2269 |
| Proprietary Name: | Metoclopramide |
| Non Proprietary Name: | Metoclopramide |
| Active Ingredient(s): | 10 mg/1 & nbsp; Metoclopramide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Metoclopramide
| Product NDC: | 0228-2269 |
| Labeler Name: | Actavis Elizabeth LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070581 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19851017 |
Package Information of Metoclopramide
| Package NDC: | 0228-2269-10 |
| Package Description: | 100 TABLET in 1 BOTTLE (0228-2269-10) |
NDC Information of Metoclopramide
| NDC Code | 0228-2269-10 |
| Proprietary Name | Metoclopramide |
| Package Description | 100 TABLET in 1 BOTTLE (0228-2269-10) |
| Product NDC | 0228-2269 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metoclopramide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19851017 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Elizabeth LLC |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |
